Holders — by stockHoldings — by fund
Prosight Management, LP
Everything this manager disclosed owning in US-listed stocks — its complete Form 13F portfolio · as of 2026-09-30 · filed with the SEC up to 45 days after quarter end · CIK 0001617201
$515.5M
disclosed book value
32
positions
11.5%
largest position share
Positions, as of 2026-09-30
top 32 of 32 · 13F covers long US-listed positions only — cash, bonds, private and foreign stakes are not disclosed · PUT/CALL tags = options positions (share-equivalents), not shares held
| # | Issuer | Shares | Value | % of book |
|---|---|---|---|---|
| 1 | LKFTLAKEFRONT BIOTHERAPEUTICS NV | 2.0M | $59.3M | 11.5% |
| 2 | STTKSHATTUCK LABS INC | 7.6M | $52.2M | 10.1% |
| 3 | JANXJANUX THERAPEUTICS INC | 2.9M | $50.9M | 9.9% |
| 4 | NKTRNEKTAR THERAPEUTICS | 785,000 | $47.5M | 9.2% |
| 5 | ABVXABIVAX SA | 376,794 | $37.3M | 7.2% |
| 6 | INSMINSMED INC | 238,088 | $27.2M | 5.3% |
| 7 | BSXBOSTON SCIENTIFIC CORP | 550,000 | $24.0M | 4.7% |
| 8 | IRTCIRHYTHM HOLDINGS INC | 200,980 | $22.8M | 4.4% |
| 9 | ALKSALKERMES PLC | 550,000 | $22.3M | 4.3% |
| 10 | PRVAPRIVIA HEALTH GROUP INC | 1.0M | $20.7M | 4% |
| 11 | MLYSMINERALYS THERAPEUTICS INC | 800,000 | $20.1M | 3.9% |
| 12 | ZYMEZYMEWORKS INC | 721,100 | $19.1M | 3.7% |
| 13 | SNDXSYNDAX PHARMACEUTICALS INC | 812,582 | $15.3M | 3% |
| 14 | KURAKURA ONCOLOGY INC | 1.3M | $13.7M | 2.6% |
| 15 | DNLIDENALI THERAPEUTICS INC | 550,700 | $11.4M | 2.2% |
| 16 | PRAXPRAXIS PRECISION MEDICINES I | 36,400 | $10.6M | 2.1% |
| 17 | HQYHEALTHEQUITY INC | 115,796 | $10.2M | 2% |
| 18 | BBIOBRIDGEBIO PHARMA INC | 150,000 | $9.9M | 1.9% |
| 19 | ALNYALNYLAM PHARMACEUTICALS INC | 37,000 | $9.1M | 1.8% |
| 20 | HUMHUMANA INC | 22,000 | $8.4M | 1.6% |
| 21 | ENOVENOVIS CORPORATION | 267,432 | $4.9M | 0.9% |
| 22 | OKURONKURE THERAPEUTICS INC | 1.3M | $3.6M | 0.7% |
| 23 | QTRXQUANTERIX CORP | 825,000 | $3.1M | 0.6% |
| 24 | GENBGENERATE BIOMEDICINES INC | 144,756 | $2.2M | 0.4% |
| 25 | ANTXAN2 THERAPEUTICS INC | 350,877 | $1.9M | 0.4% |
| 26 | PLRXPLIANT THERAPEUTICS INC | 1.6M | $1.7M | 0.3% |
| 27 | RCKTROCKET PHARMACEUTICALS INC | 595,024 | $1.6M | 0.3% |
| 28 | RNTXREIN THERAPEUTICS INC | 1.7M | $1.3M | 0.3% |
| 29 | COYACOYA THERAPEUTICS INC | 229,600 | $1.2M | 0.2% |
| 30 | CRBPCORBUS PHARMACEUTICALS HLDGS | 168,383 | $1.1M | 0.2% |
| 31 | IMRXIMMUNEERING CORP | 150,000 | $614,250 | 0.1% |
| 32 | ADCTADC THERAPEUTICS SA | 399,900 | $487,878 | 0.1% |
Source: SEC Form 13F-HR, reporting period 2026-09-30. Values are the manager's filed June-30-style quarter-end marks, not live prices. Research, not investment advice.